Synthon’s mission is to make health care more affordable, increasing access to important medicines through the provision of high quality small molecule generics, and new biological and new chemical entities. To make this happen, Synthon holds itself to the highest standards of innovation, operational excellence and environment, health & safety in everything they do – from the discovery phase in R&D across each technological platform, through to production and delivery of the finished products to our customers.

In NANOMED, Synthon will offer expertise on drug, and in particular ADC formulation approaches and provide secondments to ESRs to investigate the potential of a range of nanoparticles.